Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund Iridian Asset Management’s Stock Picks for 2013

Pharmacy services company Omnicare, Inc. (NYSE:OCR), which focuses on providing pharmacy access to long-term care and assisted living facilities, was another of Iridian’s largest holdings despite a moderate sale of shares in Q4. First Pacific Advisors, which is co-managed by Robert Rodriguez and Stephen Romick, is another major shareholder in Omnicare. Here, the company’s earnings have actually been up but quite a bit of future growth is priced in to the stock at a trailing P/E of 27. The most recent data has 13% of the outstanding shares held short, and we think we would avoid the stock.

The Iridian investment team kept its position in Baxter International Inc. (NYSE:BAX) about constant at 3.7 million shares, allowing the $38 billion market cap medical supplies company to become one of the five largest holdings. Baxter is a bit more of a conventional value thesis with trailing and forward P/Es of 16 and 13, respectively, and modest growth rates of both revenue and earnings last quarter compared to Q4 2011. Billionaire Ken Griffin’s Citadel Investment Group was buying Baxter in the third quarter of 2012 (check out more stocks Griffin was buying).

The fund had initiated a position in Motorola Solutions Inc (NYSE:MSI) between July and September, and Iridian increased its stake further during the last three months of 2012 to enter January with 4.3 million shares in its portfolio. Analyst consensus for 2014 implies a forward price-to-earnings multiple of 14, and it may be worth looking into at that pricing. Billionaire George Soros also liked the stock last summer, adding to his holdings and closing the third quarter with a total of 2.9 million shares (research more stocks Soros owns).

Disclosure: I own no shares of any stocks mentioned in this article.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!